Mitochondrial quality control in cerebral ischemia–reperfusion injury
M Wu, X Gu, Z Ma - Molecular Neurobiology, 2021 - Springer
Ischemic stroke is one of the leading causes of death and also a major cause of adult
disability worldwide. Revascularization via reperfusion therapy is currently a standard …
disability worldwide. Revascularization via reperfusion therapy is currently a standard …
Cytochrome P450 metabolism of polyunsaturated fatty acids and neurodegeneration
M Sarparast, D Dattmore, J Alan, KSS Lee - Nutrients, 2020 - mdpi.com
Due to the aging population in the world, neurodegenerative diseases have become a
serious public health issue that greatly impacts patients' quality of life and adds a huge …
serious public health issue that greatly impacts patients' quality of life and adds a huge …
PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid
Background/objectives Obesity is a risk factor in the development of type 2 diabetes mellitus
(DM2), which is associated with increased morbidity and mortality, predominantly as a result …
(DM2), which is associated with increased morbidity and mortality, predominantly as a result …
Genipin protects the liver from ischemia/reperfusion injury by modulating mitochondrial quality control
JK Shin, SM Lee - Toxicology and Applied Pharmacology, 2017 - Elsevier
Hepatic ischemia and reperfusion (IR) injury is closely linked to oxidative mitochondrial
damage. Since mitochondrial quality control (QC) plays a pivotal role in the recovery of …
damage. Since mitochondrial quality control (QC) plays a pivotal role in the recovery of …
Linoleic acid participates in the response to ischemic brain injury through oxidized metabolites that regulate neurotransmission
Abstract Linoleic acid (LA; 18: 2 n-6), the most abundant polyunsaturated fatty acid in the US
diet, is a precursor to oxidized metabolites that have unknown roles in the brain. Here, we …
diet, is a precursor to oxidized metabolites that have unknown roles in the brain. Here, we …
14, 15-EET reduced brain injury from cerebral ischemia and reperfusion via suppressing neuronal parthanatos
H Zhao, J Tang, H Chen, W Gu, H Geng… - International Journal of …, 2021 - mdpi.com
To investigate the effect of 14, 15-EET on the parthanatos in neurons induced by cerebral
ischemia and reperfusion, middle cerebral artery occlusion and reperfusion (MCAO/R) and …
ischemia and reperfusion, middle cerebral artery occlusion and reperfusion (MCAO/R) and …
Neuroprotective effects of epoxyeicosatrienoic acids
L Wang, G Luo, LF Zhang, HX Geng - Prostaglandins & other lipid …, 2018 - Elsevier
Eicosatrienoic acids (EETs) are a class of intermediates produced during arachidonic acid
metabolism mediated by cytochrome P450 epoxygenases that exert multiple physiological …
metabolism mediated by cytochrome P450 epoxygenases that exert multiple physiological …
Adipocyte specific HO-1 gene therapy is effective in antioxidant treatment of insulin resistance and vascular function in an obese mice model
Obesity is a risk factor for vascular dysfunction and insulin resistance. The study aim was to
demonstrate that adipocyte-specific HO-1 (heme oxygenase-1) gene therapy is a …
demonstrate that adipocyte-specific HO-1 (heme oxygenase-1) gene therapy is a …
Cytochrome P450-derived Epoxyeicosatrienoic Acid, the Regulation of Cardiovascular-related Diseases, and the Implication for Pulmonary Hypertension
R Lan, MJ Zhang, K Liu, FF Meng, XH Xu… - … Drugs and Therapy, 2024 - Springer
Cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid (AA) into biologically
active epoxyeicosatrienoic acids (EETs), forming a pivotal metabolic pathway (AA-CYP …
active epoxyeicosatrienoic acids (EETs), forming a pivotal metabolic pathway (AA-CYP …
Downregulation of PGC‐1α Prevents the Beneficial Effect of EET‐Heme Oxygenase‐1 on Mitochondrial Integrity and Associated Metabolic Function in Obese Mice
Background/Objectives. Obesity and metabolic syndrome and associated adiposity are a
systemic condition characterized by increased mitochondrial dysfunction, inflammation, and …
systemic condition characterized by increased mitochondrial dysfunction, inflammation, and …